In this aspect, the use ofdifferent cancer models, in vitroand in vivo, are strongly recommendedto further define the molecular interactions amongst PPAR-γ, angiogenic/antiangiogenic factors, and tumor progression markerswithin the distinct cancer types. This evidence concerns the gene PPARG and cancer.